Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Bausch & Lomb Pharmaceutical with 6 510(k) clearances. The most recent is a 510(k) clearance dated Feb 9, 1990: ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA.
| Feb 9, 1990 | ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEAK884962 · MOE | 510(k) clearances |
| Feb 13, 1989 | ADDIT. INDICATION FOR FYODOROV COLLAGEN CORNEALK884960 · MOE | 510(k) clearances |
| Feb 13, 1989 | ADDIT. INDICATIONS FOR BIO-COR II COLLAGEN CORNEALK884961 · MOE | 510(k) clearances |
| Nov 29, 1988 | LABELING CHANGES TO BIO-COR EXT COLLANGEN CORNEALK884364 · MOE | 510(k) clearances |
| Nov 29, 1988 | LABELING CHANGES TO BIO-COR II COLLANGEN CORNEALK884363 · MOE | 510(k) clearances |
| Nov 29, 1988 | LABELING CHANGES TO FYODOROV COLLAGEN CORNEAL SHLDK884362 · HQJ | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
